Table 3 Reasons for not receiving and non-persistence with anti-osteoporosis medication 1 year after fragility hip fracture
Reasons for not receiving anti-osteoporosis medication 1 year after hip fracture treatment | Total (N = 112) n (%) |
No recommendation from surgeon and primary care physician | 54 (48.2%) |
Financial constraints | 30 (26.8%) |
Patient perception against anti-osteoporosis medication | 13 (11.6%) |
Concerns about adverse medication effects | 9 (8.0%) |
Inappropriate medical condition | 6 (5.4%) |
Reasons for non-persistence with anti-osteoporosis medication 1 year after hip fracture treatment | Total (N = 50) n (%) |
Difficulties continuing to receive the medication | 25 (50.0%) |
Patient perception against anti-osteoporosis medication | 12 (24.0%) |
Surgeon or primary care physician discontinued the treatment without any specific reason | 8 (16.0%) |
Inappropriate medical condition or experienced adverse medication effects | 5 (10.0%) |